Overview AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients Status: Not yet recruiting Trial end date: 2023-09-01 Target enrollment: Participant gender: Summary This study is to obtain acute dose safety and pharmacokinetics/pharmacodynamics (PK/PD) data in a dose-response trial in prostate cancer patients. Phase: Phase 1 Details Lead Sponsor: Milton S. Hershey Medical Center